To understand the regulators of CD8+ T cell infiltration and degranulation in triple-negative breast cancer and glioblastoma (GBM) models, CRISPR screens revealed that RNA helix Dhx37 acted as a negative influencer of granzyme gene expression and IFN-γ production in CD8+ T cells [117]. Here, CD8A is linked to glioblastoma.